The Effects and Underlying Mechanisms of Cell Therapy on Blood-Brain Barrier Integrity After Ischemic Stroke
- PMID: 32928089
- PMCID: PMC7770640
- DOI: 10.2174/1570159X18666200914162013
The Effects and Underlying Mechanisms of Cell Therapy on Blood-Brain Barrier Integrity After Ischemic Stroke
Abstract
Ischemic stroke is one of the main causes of mortality and disability worldwide. However, efficient therapeutic strategies are still lacking. Stem/progenitor cell-based therapy, with its vigorous advantages, has emerged as a promising tool for the treatment of ischemic stroke. The mechanisms involve new neural cells and neuronal circuitry formation, antioxidation, inflammation alleviation, angiogenesis, and neurogenesis promotion. In the past decades, in-depth studies have suggested that cell therapy could promote vascular stabilization and decrease blood-brain barrier (BBB) leakage after ischemic stroke. However, the effects and underlying mechanisms on BBB integrity induced by the engrafted cells in ischemic stroke have not been reviewed yet. Herein, we will update the progress in research on the effects of cell therapy on BBB integrity after ischemic stroke and review the underlying mechanisms. First, we will present an overview of BBB dysfunction under the ischemic condition and cells engraftment for ischemic treatment. Then, we will summarize and discuss the current knowledge about the effects and underlying mechanisms of cell therapy on BBB integrity after ischemic stroke. In particular, we will review the most recent studies in regard to the relationship between cell therapy and BBB in tissue plasminogen activator (t-PA)-mediated therapy and diabetic stroke.
Keywords: Ischemic stroke; blood-brain barrier; neurogenesis; stem cells; tissue plasminogen activator.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Figures
References
-
- Sarmah D., Kaur H., Saraf J., Pravalika K., Goswami A., Kalia K., Borah A., Wang X., Dave K.R., Yavagal D.R., Bhattacharya P. Getting closer to an effective intervention of ischemic stroke: the big promise of stem cell. Transl. Stroke Res. 2018;9(4):356–374. doi: 10.1007/s12975-017-0580-0. - DOI - PubMed
-
- Zacharek A., Chen J., Cui X., Li A., Li Y., Roberts C., Feng Y., Gao Q., Chopp M. Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. J. Cereb. Blood Flow Metab. 2007;27(10):1684–1691. doi: 10.1038/sj.jcbfm.9600475. - DOI - PMC - PubMed
-
- Lalu M.M., Montroy J., Dowlatshahi D., Hutton B., Juneau P., Wesch N., Zhang Y. S.; McGinn, R.; Corbett, D.; Stewart, D.J.A.; A Fergusson, D. From the lab to patients: a systematic review and meta-analysis of mesenchymal stem cell therapy for stroke. Transl. Stroke Res. 2020;11(3):345–364. doi: 10.1007/s12975-019-00736-5. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
